Sebastian Lighvani, MD
NPI 1407879885 · Specialist · New York, NY
Enrolled with Medicare as Practitioner - Allergy/Immunology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Sebastian Lighvani, MD is a Specialist provider in New York, NY (NPI 1407879885).
Provider details
- NPI number
- 1407879885
- Entity type
- Individual
- Primary specialty
- SpecialistOther Service Providers
- Credential
- MD
- Sex
- Male
- Sole proprietor
- No
- License
- 230079 (NY)
Specialties & taxonomies
Other Service Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
19 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
20,386 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Test for Allergy Using Allergenic Extract95004 | 13,623 | $4 |
| Professional Service for Preparation and Provision of 1 Or More Antigens95165 | 2,996 | $17 |
| Test for Allergy Using Skin Patch95044 | 979 | $6 |
| Professional Service for Multiple Injections of Allergen95117 | 550 | $14 |
| Test for Allergy Using Allergenic Extract Injected Into Skin95024 | 498 | $9 |
| Test for Allergy Using Combination of Methods With Drug Or Biological95018 | 313 | $23 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 19 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Montelukast Sodium | 59 | 14 |
| Epinephrine | 52 | 43 |
| Ipratropium Bromide | 48 | 24 |
| Azelastine Hcl | 36 | 16 |
| Albuterol Sulfatebrand: Albuterol Sulfate Hfa | 34 | 18 |
| Azelastine/Fluticasonebrand: Azelastine-Fluticasone | 32 | 16 |
| Fluticasone/Vilanterolbrand: Breo Ellipta | 31 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$10,202 across 124 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-07-26
- Last updated
- 2007-08-20
Frequently asked questions
- What is Sebastian Lighvani's NPI number?
- Sebastian Lighvani's National Provider Identifier (NPI) is 1407879885, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Sebastian Lighvani's specialty?
- Sebastian Lighvani is listed in the NPPES registry with a primary specialty of Specialist (Other Service Providers).
- Where is Sebastian Lighvani located?
- Sebastian Lighvani's practice location on file with NPPES is 186 E 76th St, New York, NY 10021-2844.
- What is Sebastian Lighvani's phone number?
- The practice phone number listed in the NPPES registry for Sebastian Lighvani is (212) 517-3300.
- Does Sebastian Lighvani accept Medicare?
- Sebastian Lighvani is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Sebastian Lighvani's NPI active?
- Yes — Sebastian Lighvani's NPI (1407879885) is active in the NPPES registry as of the last update on 2007-08-20.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.